Peer Review History
| Original SubmissionJuly 22, 2024 |
|---|
|
Dear Dr. Sterner, Thank you very much for submitting your manuscript "A Systematic Review of the Distribution and Prevalence of Viruses Detected in the Peromyscus maniculatus Species Complex (Rodentia: Cricetidae)" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. Based on especially Reviewer 3's comments, I'd strongly advise that the authors double-check their searches thoroughly using both "deer mouse", "deer mice", "deermouse" and "deer mice" in addition to "Peromyscus" to ensure both accurate literature citing and scoping. As a side note, in response to reviewers: HPS, not HCPS, is the official term for the disease as per the WHO ICD-11, so I would recommend leaving this; likewise, "deermouse/deermice" (no space) is the correct term for all animals classified in genus _Permomyscus_ per the zoological reference standard (Wilson & Reeder). We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts. Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Jens H. Kuhn Academic Editor PLOS Pathogens Ronald Swanstrom Section Editor PLOS Pathogens Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 *********************** Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: The manuscript by Finkbeiner et al. conducted a systematic literature review to examine the distribution of viruses in North American deer mice, which has recently been proposed to be split into different species. The work reviewed the literature and conducted an analysis to identify the distribution of viruses, principally hantaviruses, arenaviruses and flaviviruses, amongst the proposed new peromyscus species. This work provides clarity of viral distributions and provides a compelling argument that the proposed P. sonoriensis is the principal reservoir host of Sin Nombre virus but that the virus can also be found in other species. Complicating this matter is the efforts by the ICTV to rework taxonomy of some of these viruses, such as the merging of SNV with NY1 hantavirus, which is hosted by P. leucopus. The manuscript is well written and the efforts of the authors are admirable. Reviewer #2: The manuscript by Finkbeiner et al. describes a systematic review conducted by the authors, in which they extracted data from all relevant papers looking at natural viral infection of Peromyscus since 2000. Since deer mice are a critical reservoir for SNV and other viruses (not to mention pathogenic bacteria and parasites), this work is a timely description of what studies have been done to date surveying infection of these mice. The authors describe weighted seroprevalence mostly for SNV and describe the strong bias toward sampling in the western United States compared to other regions. They also do a nice job discussing the complexity of how to group together host species and viruses given the recent suggested taxonomic update of the Peromyscus genus, which as they note, means that 92% of described infections need to be reclassified. The manuscript nicely distills information from 46 studies and >60,000 observations into one well-written and well-presented package. I have some comments and questions regarding a few of the authors’ choices. Reviewer #3: The authors present a review of Peromyscus-borne viral pathogens based on literature searches. The approach seems sound however details pertaining to virology seem weak and in many cases are misleading. Several references are missing which may suggest flaws in the search terms. For example, Goodfellow et al. 2021 (PMID 34549977) appears to be absent from the listed references, yet it describes similar concerns with the current knowledge of hantavirus / rodent reservoir theories. In my brief searches, this is the third paper that comes up if one searches for "Sin Nombre virus AND deer mice" .Further, there is no mention of long-term ecology / prevalence studies conducted across the USA post-1993 attempting to define indicators for predicting hantavirus spillover events. ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: It would have been helpful if the authors had included other viruses hosted by peromyscus rodents, such as Modoc virus and El Moro Canyon virus (which is also found principally in western harvest mice). In the end, the viruses/reservoirs are somewhat "fuzzy" simply because different viruses can be found in multiple species. The authors should clarify how the serology was done in these studies (e.g., "primary antigen" page 8). There is a huge difference between ELISA with nucleocapsid (highly conserved among New World hantaviruses) and Gn/Gc (more divergent), and assays such as focus reduction tests with cell culture/infectious virus. Antibodies to SNV nucleocapsid are cross reactive with Andes virus nucleocapsid, for example. This can have a profound impact on the analyses and conclusions raised by the authors. This should also be discussed in further detail in the Discussion on page 13 ("virus-specific antibody" tests). Reviewer #2: (No Response) Reviewer #3: - As stated above the description of virology in this paper needs to be improved. The basic description of virus detection methods lead to confusion and are potentially misleading. Hantaviruses are known to be serologically cross reactive and most studies conducted to date relay on basic ELSIA methodologies to determine the prevalence of hantaviruses in rodents. To determine it is SNV with certainty requires molecular techniques and often sequence analysis, which was frequently not done in earlier studies. Although serotyping ELISAs have been described, they are not commonly used therefore statements like "...studies are focused on SNV antibodies.." misleading. The studies are focused on antibodies reactive to hantaviruses. Further, the statement "Results on Powassan virus, Whitewater Arroyo Virus, Amapari virus and Mononhahela virus are inbformative in that they indicate the presence of these other hantaviruses within the P. maniculatus complex" is incorrect. Most of the viruses listed are not hantaviruses. This statement further highlights the incomplete or inaccurate knowledge of viruses presented in this manuscript. ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: Abstract. Although originally thought to be a pulmonary disease, SNV causes a cardiopulmonary disease. This is why clinical efforts are principally focused on the cardiovascular system. This should be added to the abstract (and why most of us refer to it has HCPS). Also in the abstract, do not capitalize "hantavirus (cardio)pulmonary syndrome" because it is not a proper noun. Again on page 5. Author Summary. What is meant by "locked"? Also, if referring to the families, then use Hantaviridae and Arenaviridae and italicize. Change last sentence to "major knowledge gaps that remain." Introduction. Use "deermouse" or "deer mouse" (e.g., second line of page 7), but not both. Do not capitalized "deermouse" nor "Tick-borne" because they are not a proper nouns. I also suggest the authors add "deer mouse" to the keyword list; otherwise, the risk is the paper will not be found by those who search for "deer mouse." Change "mortality rate" to "case fatality rate." They are different terms. Figure 3 is out of order. The figures should be in the order they are referenced in the text. Figure 3 should be the last figure. Reviewer #2: I am wondering why the authors chose to specifically include “viruses detected in Peromyscus” in the title, rather than simply a scoping review on SNV? As it stands, the arenaviruses and Powassan make up such a minority of the data that this might have made more sense, with just a mention of the other viruses, which is basically how it is already. In the results section starting with “other viruses were sampled less frequently…” it discusses 1 study with 353 observations for AMAV and WWAV. The mentioned of “arenavirus” tested for in only a single study, while then mentioning multiple studies later on looking at AMAV and WWAV is a bit confusing, even though I know they mean a broader Arenavirus positivity and not one that is species specific. To this end, in the last sentence of this paragraph it also says that there are multiple studies focusing on arenaviruses including WWAV and AMAV, but I think this adds to the confusion without clarifying the difference, because in the preceding paragraph is says there are only 2 studies looking at WWAV and AMAV. I would maybe make this distinction a bit more clear. Minor comments: Discussion; sentence starting with “results on Powassan virus,…” it says they are informative as the indicate the presence of these other hantaviruses, though these are not all hantaviruses. And perhaps a brief discussion about Monongahela virus and how it is not its own species as of the most recent taxonomic update might be warranted. There is a section of the discussion where the authors discuss variability in seroprevalence and how this is likely due to inconsistencies in sampling across locations and timing. It may be worth a brief discussion on what is known about how rates of SNV prevalence change in deer mouse populations depending on season and how the timing of individuals studies might influence the data in this regard. In lieu of not including timing of sampling in individual studies as part of the wider analysis Reviewer #3: - Authors include Eastern deermouse and North American deermouse in search terms but never simply deer mouse. I get zero results for North American deermouse but get 3,236 hits for deer mouse on Pubmed. Perhaps deer mouse should be included in the search criteria? Is it deermouse or deer mouse? I more commonly see it as deer mouse, yet the search terms used list "deermouse" - In the introduction the authors should differentiate between studies demonstrating susceptibility (which I assume is the term the authors use for experimental infections) versus known to harbor which appears to be based on ecological studies. For example, they cite a study by "Griffin" in 2021 (which appears to be an incomplete reference) suggesting deer mice are susceptible to SARS-Cov-2 but as far as this reviewer is aware deer mice have not been implicated as natural reservoirs for this virus. -I would encourage the authors to further analyze their datasets to highlight which studies conducted in-depth rodent identification techniques such as cytochrome sequencing to determine rodent species as opposed to those which simply used visual clues. - Many critical references are missing which makes this reviewer wonder if the search terms used need to be expanded. To this point, there are several papers from studies conducted in Canada that seem to have been missed by the terms used. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols
|
| Revision 1 |
|
PPATHOGENS-D-24-01530R1 A Systematic Review of the Distribution and Prevalence of Viruses Detected in the Peromyscus maniculatus Species Complex (Rodentia: Cricetidae) PLOS Pathogens Dear Dr. Sterner, Thank you for submitting your manuscript to PLOS Pathogens. After careful consideration, we feel that it has merit but does not fully meet PLOS Pathogens's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days Apr 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plospathogens@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/ppathogens/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Ronald Swanstrom Section Editor PLOS Pathogens Ronald Swanstrom Section Editor PLOS Pathogens Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 Journal Requirements: 1) Please upload a copy of Figures 1-7 which you refer to in your text. Please note that the figures should be uploaded as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/plospathogens/s/figures 2) We have noticed that you have uploaded Supporting Information files, but you have not included a complete list of legends. Please add a full list of legends for the supplementary tables after the references list. 3) For maps included in the manuscript: Please (a) provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and (b) provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license. Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted. If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license. If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps: * U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov) * PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl) * Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/). 4) All authors should have affiliations, and no affiliations should be included unless linked to an author. Please ensure that the affiliations of Nathan Upham and Beckett Sterner are provided in the title page. Please also ensure that the affiliation of Beckett Sterner is included in the online submission form. 5) As required by our policy on Data Availability, please ensure your manuscript or supplementary information includes the following: - A numbered table of all studies identified in the literature search, including those that were excluded from the analyses. - For every excluded study, the table should list the reason(s) for exclusion. - If any of the included studies are unpublished, include a link (URL) to the primary source or detailed information about how the content can be accessed. - A table of all data extracted from the primary research sources for the systematic review and/or meta-analysis. The table must include the following information for each study: - Name of data extractors and date of data extraction - Confirmation that the study was eligible to be included in the review. - All data extracted from each study for the reported systematic review and/or meta-analysis that would be needed to replicate your analyses. - If data or supporting information were obtained from another source (e.g. correspondence with the author of the original research article), please provide the source of data and dates on which the data/information were obtained by your research group. - If applicable for your analysis, a table showing the completed risk of bias and quality/certainty assessments for each study or outcome. Please ensure this is provided for each domain or parameter assessed. For example, if you used the Cochrane risk-of-bias tool for randomized trials, provide answers to each of the signalling questions for each study. If you used GRADE to assess certainty of evidence, provide judgements about each of the quality of evidence factor. This should be provided for each outcome. - An explanation of how missing data were handled. This information can be included in the main text, supplementary information, or relevant data repository. Please note that providing these underlying data is a requirement for publication in this journal, and if these data are not provided your manuscript might be rejected. Reviewers' Comments: Reviewer's Responses to Questions Part I - Summary Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship. Reviewer #1: The authors have addressed the issues from the previous manuscript but have not addressed El Moro Canyon virus that has been detected in deer mice (see PMID 9025697). It is not clear that other hantaviruses might infect deer mice, thus the assertion that seropositive deer mice must be infected with SNV is not justified. Reviewer #2: The authors have addressed my comments and those of the other reviewers and editor Reviewer #3: (No Response) ********** Part II – Major Issues: Key Experiments Required for Acceptance Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions. Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject". Reviewer #1: There are no experiments; this is an analysis of the literature. Reviewer #2: None. Reviewer #3: (No Response) ********** Part III – Minor Issues: Editorial and Data Presentation Modifications Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. Reviewer #1: None. Reviewer #2: (No Response) Reviewer #3: The authors have addressed my main concerns in their revised submission. I disagree with the authors responses that the years ecological work conducted on SNV and other hantaviruses are out of scope for this work. I would prefer to see some further discussion on that topic since those studies represent a vast amount of knowledge that is in my opinion highly relevant to this topic. ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 2 |
|
Dear Dr. Sterner, We are pleased to inform you that your manuscript 'A Systematic Review of the Distribution and Prevalence of Viruses Detected in the Peromyscus maniculatus Species Complex (Rodentia: Cricetidae)' has been provisionally accepted for publication in PLOS Pathogens. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Jens H. Kuhn Academic Editor PLOS Pathogens Ronald Swanstrom Section Editor PLOS Pathogens Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 *********************************************************** Reviewer Comments (if any, and for reference): |
| Formally Accepted |
|
Dear Dr. Sterner, We are delighted to inform you that your manuscript, "A Systematic Review of the Distribution and Prevalence of Viruses Detected in the Peromyscus maniculatus Species Complex (Rodentia: Cricetidae)," has been formally accepted for publication in PLOS Pathogens. We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens. Best regards, Sumita Bhaduri-McIntosh Editor-in-Chief PLOS Pathogens orcid.org/0000-0003-2946-9497 Michael Malim Editor-in-Chief PLOS Pathogens orcid.org/0000-0002-7699-2064 |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .